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Abstract
Background: We report a case of pulmonary sarcoma which is a rare cause of the common
symptom of dyspnea.
Case presentation: A fifty-one year old previously healthy male presented to the emergency
room with complaints of dyspnea on exertion. A cardiac workup including an exercise stress test
was negative but an echocardiography showed pulmonary stenosis. Cardiac MRI showed a large
mass extending from the pulmonic valve to both the right and left pulmonary arteries suggestive of
sarcoma. A complete resection and repair of the pulmonary artery was done and adjuvant
chemotherapy with doxorubicin and ifosfamide was recommended. The patient is currently disease
free after eighteen months.
Conclusion: Pulmonary artery sarcomas are a difficult diagnosis. The diagnosis may remain elusive
for some time until the proper imaging techniques are utilized to make a diagnosis. Earlier and
accurate diagnosis may lead to earlier interventions and improve survival.
Background
Dyspnea is a frequent presentation to the emergency
room. The differential diagnosis is extensive and often the
diagnosis remains obscure. Pulmonary sarcomas are a rare
cause of dyspnea, but do present as such and are often ini-
tially misdiagnosed.
Case Presentation
A 51 year old previously healthy male presented to the
emergency room with complaints of dyspnea, chest pain
and palpitations while playing tennis. This was the second
time over the last month that he experienced some palpi-
tations and dyspnea with exertion. Previously, the patient
was ruled out for a myocardial infarction and had a stress
echocardiogram which showed mild/moderate pulmonic
stenosis, normal right ventricle, and thickened pulmonic
valve with doming, but otherwise normal stress test. He
was sent home from the emergency room with follow-up
with his primary care physician and cardiologist. His car-
diologist ordered a cardiac MRI to further evaluate the
pulmonic valve. The MRI revealed a large mass starting
near the pulmonic valve and extending into the main pul-
monary artery and 4 cm into the right pulmonary artery
and 3 cm into the left pulmonary artery (Fig 1). The MRI
findings were suspicious for a pulmonary artery sarcoma.
The patient was admitted into the hospital for further
evaluation of the mass. Although the patient's vital signs
were stable with normal oxygen saturation he was started
Published: 29 June 2007
International Seminars in Surgical Oncology 2007, 4:14 doi:10.1186/1477-7800-4-14
Received: 17 May 2006
Accepted: 29 June 2007
This article is available from: http://www.issoonline.com/content/4/1/14
© 2007 Hsing et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.International Seminars in Surgical Oncology 2007, 4:14 http://www.issoonline.com/content/4/1/14
Page 2 of 4
(page number not for citation purposes)
on heparin due to suspicion of a thromboembolism. CT
scan of the chest was done which showed the large pulmo-
nary artery mass and 2 small 9 mm nodular densities of
the right lung without lymphadenopathy (Fig 2). PET-
FDG showed uptake in the pulmonary artery trunk, but
the 2 nodules did not show abnormal FDG uptake. Cardi-
othoracic surgery was consulted and the pulmonary artery
mass and 2 lung wedge resections were completely
excised. Frozen section evaluation was consistent with sar-
coma.
Gross pathology showed a large intimal sarcoma filling
the pulmonary artery (Fig 3). It infiltrated the arterial
media without extension into the adventitia. The neo-
plasm consisted of spindled and stellate-shaped cells
deposited in variably myxoid stroma (Fig 4). The 2 lung
wedges were positive for metastatic sarcoma.
The patient tolerated the surgery well and was discharged
with oncology follow-up as an outpatient. Adjuvant
chemotherapy with doxorubicin and ifosfamide was initi-
ated soon thereafter. Eighteen months later and after 7
cycles of chemotherapy, he continues to remain disease
free by imaging.
Conclusion
Sarcoma of the great vessels are rare and are usually found
in the aorta (most often abdominal), inferior vena cava,
or pulmonary artery. Typically, these sarcomas are rare
and highly lethal that previously were diagnosed during
surgery or autopsy. Patients typically present between the
ages of 22 and 81 with female sex predominance. The
prognosis is poor with a mean survival of 12 months after
onset of symptoms and 1 and 2 year survival rates of 22%
and 7% respectively[1]. The presentation usually corre-
sponds to the location of the sarcoma. In the case of a pul-
monary artery sarcoma dyspnea, chest pain, cough and
hemoptysis are the most frequent complaints. A common
error involves diagnosing a pulmonary thromboembo-
lism and treating it as such. There have been a number of
case reports and several literature reviews discussing the
findings of a pulmonary artery sarcoma. Older case
reports usually only made the correct diagnosis during
surgery or autopsy and only after a prolonged period of
symptoms[2]. More recent advances in imaging technol-
ogy with multi-slice CT and MRI have enabled better tis-
sue and anatomy characterization [3-5]. This has enabled
making the correct diagnosis earlier and differentiating it
from other pulmonary vascular pathologies, namely
thromboembolism. Quicker diagnosis allows earlier
potential curative treatment with surgical resection and
CT scan showing extensive involvement of the main pulmo- nary artery and into the right trunk Figure 2
CT scan showing extensive involvement of the main pulmo-
nary artery and into the right trunk.
Cardiac MRI showing the sarcoma arising from right ventricle  outflow tract to both the right and left pulmonary artery Figure 1
Cardiac MRI showing the sarcoma arising from right ventricle 
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adjuvant chemotherapy with or without radiation. At
present it is unclear whether earlier diagnosis followed by
earlier initiation of treatment leads to improved overall
survival.
The World Health Organization (WHO) classify sarcomas
on the basis of hematoxylin-eosin, Masson-trichrome,
and periodic acid-Schiff stained sections[6]. Sarcomas of
the great vessels are usually one of three types: angiosar-
coma, leiomyosarcoma, or intimal sarcoma. Leiomyosar-
comas arise from the smooth muscle, are spindle cell
shaped and stain for desmin and actin. Angiosarcomas
arise from the endothelial cells of blood vessels and stain
for filament proteins vimentin, factor VIII, and CD34. Sar-
comas that don't fit into one of the other categories are
termed "intimal." The histologic and immunohistochem-
ical findings are summarized in Table 1. Pulmonary artery
sarcomas often arise from the intimal layer of the pulmo-
nary trunk and spread either antegrade into the pulmo-
nary artery branches or retrograde into the pulmonic valve
and right ventricle[7]. Metastases are usually found in the
lungs, but other sites include kidney, brain, lymph node
and skin[6].
The mainstay of treatment for sarcoma is surgical resec-
tion as this remains the only potentially curative modal-
ity. Adjuvant radiation and chemotherapy can be
considered following surgical excision although their role
remains undefined. An approximate 20% response rate
can be expected with a combination chemotherapy regi-
men involving an anthracycline and an alkylating agent,
however, the value of this regimen in the adjuvant setting
for pulmonary artery sarcoma is unclear[8,9].
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Low field and high field microscopic findings showing spindle cells with hyperchromatic nuclei in myxoid background Figure 4
Low field and high field microscopic findings showing spindle cells with hyperchromatic nuclei in myxoid background.
Gross pathology of the sarcoma invading the pulmonary  artery Figure 3
Gross pathology of the sarcoma invading the pulmonary 
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Table 1: Summary of the common types of sarcomas of the great vessels
Histologic Type Cell of Origin Histologic feature Immunohistochemical
Angiosarcoma Blood vessels Endothelial cells Vimentin, Factor VIII, CD 34
Leiomyosarcoma Smooth muscle Spindle shape Desmin, Actin
Intimal Unknown Undifferentiated cells Varies